Vaccines

Research examining the development of vaccines

Published and Preprint Papers

Vaccine Types

Title

Altmetric

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

adenovirus vaccine

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.

adenovirus vaccine

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.

adenovirus vaccine

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.